BioCentury
ARTICLE | Distillery Therapeutics

Autoimmune

December 19, 2017 8:58 PM UTC

Cell culture and mouse studies suggest inhibiting Bcl-XL could help treat scleroderma. In primary human dermal fibroblasts cultured on a stiff matrix to mimic fibrotic conditions, siRNA targeting Bcl-...

BCIQ Company Profiles

Harvard Medical School

BCIQ Target Profiles

Bcl-XL